Brancaster Pharma Limited has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that the Patient Information Leaflet (PIL) included in the cartons for the batches referenced in the notification was released with an outdated version.
Regulatorische Updates23. Aug. 2026•1 Min. Lesezeit
Brancaster Pharma reports outdated PIL on notified batches
Brancaster Pharma informed the MHRA that cartons for the listed batches were supplied with an outdated Patient Information Leaflet.
Zusammengestellt vom PharmaCountry-Team · Quelle: MHRA
Themen:#Patient Information Leaflet#batch notification#regulatory compliance#pharmaceutical labeling#MHRA
Bewertungen
(0)
(0)
(0)
(0)
(0)
Weitere Artikel
Alle Einblicke anzeigenStudien & Berichte
Global Finished Dosage Manufacturing Landscape 2026
5. Okt. 2026
Regulatorische UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28. Sept. 2026
AnalysePharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28. Sept. 2026
Bewertung hinterlassen